COST Action CA18218


COVID-19 has affected many countries in Europe in beyond. There is currently a growing interest to quantify the disease burden of COVID-19, in order to measure its population health impact and compare it to other diseases.

On this page, we compile burden of disease resources specifically focussed on COVID-19.

DALY calculation methods for COVID-19

Wyper GM, Assunção RM, Colzani E, Grant I, Haagsma JA, Lagerweij G, Von der Lippe E, McDonald SA, Pires SM, Porst M, Speybroek N, Devleesschauwer B. Burden of disease methods: a guide to calculate COVID-19 disability-adjusted life years. SocArXiv. 2020. doi: 10.31235/

Devleesschauwer B, McDonald SA, Speybroeck N, Wyper GM. Valuing the years of life lost due to COVID-19: the differences and pitfalls. Int J Public Health. 2020;65:719–720. doi: 10.1007/s00038-020-01430-2

DALY calculations for COVID-19  peer-reviewed

Zhao J, Jin H, Li X, Jia J, Zhang C, Zhao H, Ma W, Wang Z, He Y, Lee J, Zhang D, Yin B, Zheng W, Wang H, Pennington M. Disease burden attributable to the first wave of COVID-19 in China and the effect of timing on the cost-effectiveness of movement restriction policies. Value Health. 2021; in press. doi: 10.1016/j.jval.2020.12.009

Ortiz-Prado E, Simbaña-Rivera K, Barreno LG, Diaz AM, Barreto A, Moyano C, Arcos V, Vásconez-González E, Paz C, Simbaña-Guaycha F, Molestina-Luzuriaga M, Fernández-Naranjo R, Feijoo J, Henriquez AR, Adana L, Cortés AL, Fletcher I, Lowe R. Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador. PLOS Negl Trop Dis. 2020;15(1):e0008958. doi: 10.1371/journal.pntd.0008958

Mitra AK, Payton M, Kabir N, Whitehead A, Ragland KN, Brown A. Potential Years of Life Lost due to COVID-19 in the United States, Italy, and Germany: an old formula with newer ideas. Int J Environ Res Public Health. 2020;17(12):4392. doi: 10.3390/ijerph17124392

Oh IH, Ock M, Jang SY, Go DS, Kim YE, Jung YS, Kim KB, Park H, Jo MW, Yoon SJ. Years of Life Lost attributable to COVID-19 in high-incidence countries. J Korean Med Sci. 2020;35(32):e300. doi: 10.3346/jkms.2020.35.e300

Bell D, Schultz Hansen K, Kiragga AN, Kambugu A, Kissa J, Mbonye AK. Predicting the impact of COVID-19 and the potential impact of the public health response on disease burden in Uganda. Am J Trop Med Hyg. 2020; in press. doi: 10.4269/ajtmh.20-0546

Tchole AIM, Li ZW, Wei JT, Ye RZ, Wang WJ, Du WY, Wang HT, Yin CN, Ji XK, Xue FZ, Bachir AM, Zhao L, Cao WC, Cheeloo EcoHealth Consortium (CLEC). Epidemic and control of COVID-19 in Niger: quantitative analyses in a least developed country. J Glob Health. 2020;10(2):020513. doi: 10.7189/jogh.10.020513

Nurchis MC, Pascucci D, Sapienza M, Villani L, D’Ambrosio F, Castrini F, Specchia ML, Laurenti P, Damiani G. Impact of the burden of COVID-19 in Italy: Results of Disability-Adjusted Life Years (DALYs) and productivity loss. Int J Environ Res Public Health. 2020;17:4233. doi: 10.3390/ijerph17124233

Jo MW, Go DS, Kim R, Lee SW, Ock M, Kim YE, Oh IH, Yoon SJ, Park H. The burden of disease due to COVID-19 in Korea using Disability-Adjusted Life Years. J Korean Med Sci. 2020;35(21):e199. doi: 10.3346/jkms.2020.35.e199

DALY calculations for COVID-19 non peer-reviewed

John D, Narassima MS, Menon JC, GR Jammy GR. Estimation of economic burden of COVID-19 using Disability-Adjusted Life Years (DALYs) and Productivity Losses in Kerala state, India. Research Square. December 2, 2020. doi: 10.21203/

Mirzaee N, Barouni M, Goudarzi R, Jahani Y, Haghdoost AA, Gohari MA, Nakhaeizadeh M, McFarland W, Sharifi H. Prediction the burden of COVID-19 in Iran: Application of disability-adjusted life years (DALYs). Research Square. September 21, 2020. doi: 10.21203/

Mohanty SK, Dubey M, Mishra US, Sahoo U. Impact of COVID-19 attributable deaths on longevity, premature mortality and DALY: Estimates of USA, Italy, Sweden and Germany. medRxiv. July 07, 2020. doi: 10.1101/2020.07.06.20147009

Mohanty SK, Sahoo U, Mishra US, Dubey M. Age pattern of premature mortality under varying scenarios of COVID-19 infection in India. medRxiv. June 12, 2020. doi: 10.1101/2020.06.11.20128587

Khan S. Can we estimate the Disability Adjusted Life-Years (DALYs) for COVID-19 yet?

COVID-19 and burden of disease context

Noy I, Doan N, Ferrarini B, Park D. Measuring the economic risk of COVID‐19. Global Policy. 2020;11(4):413-23. doi: 10.1111/1758-5899.12851

Azarpazhooh MR, Morovatdar N, Avan A, Phan TG, Divani AA, Yassi N, Stranges S, Silver B, Biller J, Tokazebani Belasi M, Kazemi Neya S, Khorram B, Frydman A, Nilanont Y, Onorati E, Di Napoli M. COVID-19 pandemic and burden of non-communicable diseases: an ecological study on data of 185 countries. J Stroke Cerebrovasc Dis. 2020;29(9):105089. doi: 10.1016/j.jstrokecerebrovasdis.2020.105089

Wyper GM, Assunção RM, Cuschieri S, Devleeschauwer B, Fletcher E, Haagsma JA, Hilderink H, Idavain J, Lesnik T, Von der Lippe E, Majdan M, Santric-Milicevic M, Pallari E, Peñalvo JL, Pires SM, Plass D, Santos JV, Stockton DL, Thomsen ST, Grant I. Population vulnerability to COVID-19 in Europe: a burden of disease analysis. Arch Public Health. 2020;78:47. doi: 10.1186/s13690-020-00433-y

About COST

COST (European Cooperation in Science and Technology – see is a unique platform where European researchers can jointly develop their ideas and initiatives across all scientific disciplines through trans-European networking of nationally funded research. COST is supported by the European Union (EU) Horizon 2020 Programme.

Get in touch


EU Flag

COST is supported by the EU Framework Programme Horizon 2020

Website by  woluweb mini